DuPont de Nemours Inc vs Herbalife Nutrition Ltd — how do they compare? DuPont de Nemours Inc trades at $134.41 (market cap $18.12B), while Herbalife Nutrition Ltd trades at $12.24 (market cap $1.27B). The key difference: DuPont de Nemours Inc is far larger — about 14.3× Herbalife Nutrition Ltd's market cap, and DuPont de Nemours Inc pays a 1.79% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| DD | HLF | |
|---|---|---|
Market Cap | $18.12B | $1.27B |
Sector | Basic Materials | Consumer Staples |
52-Week High | $154.59 | $19.96 |
52-Week Low | $87.72 | $7.75 |
Enterprise Value | $20.58B | $3.00B |
Dividend Yield | 1.79% | — |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $132.66, down 1.5% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong gross margins (35.01%) but negative net income margin (-0.42%) and ROE (-0.16%). Analyst consensus remains bullish with a $227.20 price target (71% upside), though the company faces legal challenges and persistent net cash outflows. Recent developments include water technology upgrades and a 3:1 reverse stock split effective June 2026.
While analyst optimism and valuation discount to price target suggest potential upside, investors face significant risks including ongoing litigation over 'forever chemicals,' weak profitability trends, and concerning cash flow patterns. The stock's current technical weakness near support levels requires careful monitoring of Q2 2026 earnings results due July 2026.
Herbalife (HLF) trades at $13.10, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 77.78% gross margin and attractive valuation metrics including a P/E of 5.75 and P/S of 0.27. Recent Q1 2026 earnings beat expectations with EPS of $0.64 versus $0.607 expected, while the company completed a $1.45 billion debt refinancing in April 2026 to strengthen its balance sheet.
The outlook remains positive with analyst consensus favoring Buy ratings (57.69%) and improving debt-to-asset ratios from 82.84% in 2024 to 71.67% in 2025. Key risks include high leverage, competitive pressures in the nutrition space, and regional market volatility. The stock offers value appeal given low multiples and recent strategic initiatives to expand digital health offerings.
Trailing returns across standard periods
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →